Mpox in African countries (Update 3)
31 Oct 2024
The World Health Organization reports continuing transmission of mpox in Africa. Countries reporting laboratory-confirmed cases from 1 January 2024 to the latest update of 27 October 2024 are:
Democratic Republic of the Congo: 8 607 cases (25 deaths)
Burundi: 1 509 cases
Uganda: 220 cases (1 death)
Nigeria: 108 cases
Côte d’Ivoire: 89 cases (2 deaths)
Central African Republic: 64 cases (2 deaths)
South Africa: 25 cases (3 deaths)
Congo: 22 cases
Liberia: 20 cases
Kenya: 14 cases (1 death)
Cameroon: 6 cases (2 deaths)
Rwanda: 6 cases
Morocco: 3 cases
Gabon: 2 cases
Ghana: 2 cases
Zimbabwe: 2 cases
Guinea: 1 case
Zambia: 1 case
Advice to Travellers
Mpox (Monkeypox) is a rare viral infection that causes a high temperature (fever) and a body rash lasting a few weeks.
If you are travelling to countries where mpox is present you should:
-
practise careful hand hygiene, especially if you are visiting or caring for ill friends and relatives
- avoid contact with monkeys and rodents (for example rats, mice, squirrels), including their blood and other parts, and avoid eating undercooked meat from any animals
- wear protective clothing, including gloves, if you are involved in the slaughter of, or care and/or treatment of animals in these regions
If you are travelling to any destination and will be sexually active during travel (including GBMSM) you should:
- be aware of the risk of mpox
- talk to sexual partners about their sexual health, ask if they have symptoms and always practise safe sex
- avoid close physical contact, including sexual contact, with someone who is unwell and may have mpox
- always share contact details with new sexual partners to help limit further spread of infection if you become infected
- maintain good personal hygiene and wash hands often, avoid touching eyes, nose and mouth with unwashed hands
- know the symptoms of mpox and check yourself regularly; be aware it can take up to 3 weeks for symptoms to appear after contact with an infected person
- seek health advice and isolate yourself from others whilst waiting to get tested if you have symptoms of mpox
Vaccine
The vaccination against mpox is only available through the NHS to those at high risk of exposure, and is not currently available to purchase privately or at a pharmacy. For more information about the mpox vaccine, including information on high-risk groups and eligibility, see:
- NHS inform (Scotland)
- NHS.UK (England)
- NIdirect (N.Ireland)
- Public Health Wales
For further information on the disease and how you can protect yourself, see the Mpox, Sexual Health Risks and LGBT travellers pages.
After Travel
Seek medical advice during, and for 21 days after travelling if you develop symptoms of mpox and:
- you have have returned from from a country where mpox is present. Also make sure you are checked for malaria if returning from these countries as the symptoms may appear similar, or
- had close contact with someone who may have mpox
Advice if returning to the UK from a country where Clade I mpox exists (currently Central and East African countries)
- If you return from a country where there is an outbreak of the potentially more severe mpox Clade I to a UK airport or port of entry and have any symptoms of mpox, you should speak to a member of port or border staff for advice.
- If you develop symptoms of mpox within 21 days of return from an affected country, you should isolate at home and call NHS 24 (Scotland) or NHS 111 (rest of UK) for advice, reporting details of your travel.
- If you are travelling to an area affected by mpox clade I virus to work in response to the outbreak, you should register with the UKHSA Returning Workers Scheme (RWS). Further information on the Returning Workers Scheme is available here.
The United Kingdom Health Security Agency (UKHSA) classifies Clade I mpox (currently reported in Central and East African countries) as a high consequence infectious disease (HCID). *For health professionals: operational case definitions are published here.
Advice to travellers will be updated as appropriate.